Anbio Biotechnology (NNNN)

Anbio Biotechnology will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$5.00 - $6.00

Shares Offered

1,600,000

Deal Size

$8.80M

Anbio Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	4.33	2.25	10.01
Depreciation & Amortization	0	0.01	0.01
Other Operating Activities	-4.97	-1.37	-5.57
Operating Cash Flow	-0.63	0.9	4.45
Operating Cash Flow Growth	-	-79.81%	-
Change in Investments	-	1.73	-1.53
Investing Cash Flow	0.29	1.73	-1.53
Other Financing Activities	0.1	-0.04	-
Financing Cash Flow	0.1	-0.04	-
Net Cash Flow	-0.25	2.59	2.92
Free Cash Flow	-0.63	0.9	4.45
Free Cash Flow Growth	-	-79.81%	-
Free Cash Flow Margin	-6.67%	13.38%	18.90%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).